申请人:THE GENERAL HOSPITAL CORPORATION
公开号:US20160052890A1
公开(公告)日:2016-02-25
The disclosure provides compounds and pharmaceutical compositions of the compounds useful for treating chronic and acute bacterial infections. Certain of the compounds are compounds and salts of general Formula VIII Certain compounds of this disclosure are MvfR inhibitors. MvfR inhibitors reduce the formation of antibiotic tolerant bacterial strains and are useful for treating Gram-negative bacterial infections and reducing the virulence of
Pseudomonas aeruginosa.
Methods of treating bacterial infections in a patient, including
Pseudomonas aeruginosa
infections, are also provided by the disclosure.
本公开提供了化合物和药物组合物,这些化合物对治疗慢性和急性细菌感染有用。其中一些化合物是通式VIII的化合物和盐。本公开的某些化合物是MvfR抑制剂。MvfR抑制剂减少抗生素耐药细菌株的形成,对治疗革兰氏阴性细菌感染和减少铜绿假单胞菌的毒性有用。本公开还提供了治疗患者细菌感染的方法,包括铜绿假单胞菌感染。